2,3-Dimercaptopropanol, a thiol chelator, alleviates gastroduodenal ulcers in rats
Meshal Al Moutaery
Prince Sultan Cardiac Center, Armed Forces Hospital, Riyadh, Saudi Arabia
Search for more papers by this authorHannan Al Rayes
Department of Medicine, Armed Forces Hospital, Riyadh, Saudi Arabia
Search for more papers by this authorRamaiz Al Swailam
Department of Medicine, Armed Forces Hospital, Riyadh, Saudi Arabia
Search for more papers by this authorIbrahim Elfaki
Research Center, Armed Forces Hospital, PO Box 7897 (W-912), Riyadh 11159, Saudi Arabia
Search for more papers by this authorHaseeb Ahmad Khan
Prince Sultan Research Chair for Environment and Wildlife, King Saud University, Riyadh, Saudi Arabia
Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia
Search for more papers by this authorAbdullah Saleh Alhomida
Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia
Search for more papers by this authorMohammad Arshaduddin
Research Center, Armed Forces Hospital, PO Box 7897 (W-912), Riyadh 11159, Saudi Arabia
Search for more papers by this authorCorresponding Author
Mohammad Tariq
Research Center, Armed Forces Hospital, PO Box 7897 (W-912), Riyadh 11159, Saudi Arabia
Correspondence and reprints: [email protected]Search for more papers by this authorMeshal Al Moutaery
Prince Sultan Cardiac Center, Armed Forces Hospital, Riyadh, Saudi Arabia
Search for more papers by this authorHannan Al Rayes
Department of Medicine, Armed Forces Hospital, Riyadh, Saudi Arabia
Search for more papers by this authorRamaiz Al Swailam
Department of Medicine, Armed Forces Hospital, Riyadh, Saudi Arabia
Search for more papers by this authorIbrahim Elfaki
Research Center, Armed Forces Hospital, PO Box 7897 (W-912), Riyadh 11159, Saudi Arabia
Search for more papers by this authorHaseeb Ahmad Khan
Prince Sultan Research Chair for Environment and Wildlife, King Saud University, Riyadh, Saudi Arabia
Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia
Search for more papers by this authorAbdullah Saleh Alhomida
Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia
Search for more papers by this authorMohammad Arshaduddin
Research Center, Armed Forces Hospital, PO Box 7897 (W-912), Riyadh 11159, Saudi Arabia
Search for more papers by this authorCorresponding Author
Mohammad Tariq
Research Center, Armed Forces Hospital, PO Box 7897 (W-912), Riyadh 11159, Saudi Arabia
Correspondence and reprints: [email protected]Search for more papers by this authorAbstract
Earlier studies have implicated reactive oxygen species and transitional metals in the pathogenesis of gastric lesions. In this study, we have evaluated the effect of 2,3-dimercaptopropanol (DMP), a thiol compound and metal chelator, on chemically induced gastroduodenal ulcers in rats. Acid secretion studies were undertaken using pylorus-ligated rats pretreated with DMP (3–100 mg/kg, i.p.). The effect of orally administered DMP on cysteamine-induced duodenal ulcers and ethanol-induced gastric ulcers was also tested. The level of nonprotein sulfhydryls (NP-SH) and gastric wall mucus was measured in the glandular stomach of rats treated with ethanol. None of the dose of DMP affected the volume or acidity of gastric secretion. Low doses of DMP (3 and 10 mg/kg) significantly reduced cysteamine-induced duodenal ulcers, whereas the high doses (30 and 100 mg/kg) were ineffective in this model. All the doses of DMP significantly and dose dependently attenuated ethanol-induced gastric lesions. The adverse effects of ethanol on gastric wall mucus and NP-SH were significantly and dose dependently reversed by DMP. In conclusion, the protective effects of DMP appear to be independent of gastric acid secretion and may be associated with counteracting the oxidative stress by replenishing glutathione and reducing the pool of transition metals.
References
- 1 Wang Y.R., Richter J.E., Dempsey D.T. Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann. Surg. (2010) 251 51–58.
- 2 Kwon J.H., Choi M.G., Lee S.W. et al. Trends of Gastrointestinal diseases at a single institution in Korea over the past two decades. Gut Liver (2009) 3 252–258.
- 3 Sadic J., Borgström A., Manjer J., Toth E., Lindell G. Bleeding peptic ulcer – time trends in incidence, treatment and mortality in Sweden. Aliment. Pharmacol. Ther. (2009) 30 392–398.
- 4 Ali T., Roberts D.N., Tierney W.M. Long-term safety concerns with proton pump inhibitors. Am. J. Med. (2009) 122 896–903.
- 5 Vakil N. Helicobacter pylori: factors affecting eradication and recurrence. Am. J. Gastroenterol. (2005) 100 2393–2394.
- 6 Zhu A., Kaunitz J. Gastroduodenal mucosal defense. Curr. Gastroenterol. Rep. (2008) 10 548–554.
- 7 Erbil Y., Türkoglu U., Barbaros U. et al. Oxidative damage in an experimentally induced gastric and gastroduodenal reflux model. Surg. Innov. (2005) 12 219–225.
- 8 Kwiecień S., Brzozowski T., Konturek S.J. Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J. Physiol. Pharmacol. (2002) 53 39–50.
- 9 Dursun H., Bilici M., Albayrak F. et al. Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue. BMC Gastroenterol. (2009) 9 36.
- 10 Koc M., Imik H., Odabasoglu F. Gastroprotective and anti-oxidative properties of ascorbic acid on indomethacin-induced gastric injuries in rats. Biol. Trace Elem. Res. (2008) 126 222–236.
- 11 Sehirli O., Tatlidede E., Yüksel M. et al. Antioxidant effect of alpha-lipoic acid against ethanol-induced gastric mucosal erosion in rats. Pharmacology (2008) 81 173–180.
- 12 Suzuki Y., Ishihara M., Segami T., Ito M. Anti-ulcer effects of antioxidants, quercetin, alpha-tocopherol, nifedipine and tetracycline in rats. Jpn. J. Pharmacol. (1998) 78 435–441.
- 13 Boyd S.C., Sasame H.A., Boyd M.R. Gastric glutathione depletion and acute ulcerogenesis by diethylmaleate given subcutaneously to rats. Life Sci. (1981) 28 2987–2992.
- 14 Szabo S., Trier J.S., Frankel P.W. Sulfhydryl compounds may mediate gastric cytoprotection. Science (1981) 214 200–202.
- 15 Olaleye S.B., Adaramoye O.A., Erigbali P.P., Adeniyi O.S. Lead exposure increases oxidative stress in the gastric mucosa of HCl/ethanol-exposed rats. World J. Gastroenterol. (2007) 13 5121–5126.
- 16 Khomenko T., Szabo S., Deng X., Ishikawa H., Anderson G.J., McLaren G.D. Role of iron in the pathogenesis of cysteamine-induced duodenal ulceration in rats. Am. J. Physiol. Gastrointest. Liver Physiol. (2009) 296 G1277–G1286.
- 17 Flora S.J., Bhadauria S., Pant S.C., Dhaked R.K. Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats. Life Sci. (2005) 77 2324–2337.
- 18 Flora S.J., Flora G., Saxena G., Mishra M. Arsenic and lead induced free radical generation and their reversibility following chelation. Cell. Mol. Biol. (2007) 53 26–47.
- 19 Hantson P., Lievens M., Mahieu P. Accidental ingestion of a zinc and copper sulfate preparation. J. Toxicol. Clin. Toxicol. (1996) 34 725–730.
- 20 Franco L. Role of nitric oxide in prevention of ethanol-induced gastric damage by CuNSN a copper-chelating compound. Inflamm. Res. (1995) 44 27–29.
- 21 Ablin J., Shalev O., Okon E., Karmeli F., Rachmilewitz D. Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflamm. Bowel Dis. (1999) 5 253–261.
- 22 Shay H., Kumarove S.A., Fels S.A. et al. A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology (1945) 5 43–61.
- 23 Szabo S. Animal model of human disease. Cysteamine induced acute and chronic duodenal ulcer in the rat. Am. J. Pathol. (1978) 93 273–276.
- 24 Natale G., Lazzeri G., Blandizzi C. et al. Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage. Toxicol. Appl. Pharmacol. (2001) 174 17–26.
- 25 Schiantarelli P., Cadel S., Folco G.C. Gastroprotective effects of mornifulmate, an esterified anti-inflammatory drug. Arzneimittelforschung (1984) 34 885–890.
- 26 Corne S.J., Morrisey S.M., Woods R.J. A method for the quantitative estimation of gastric barrier mucus. J. Physiol. (1974) 242 116–117.
- 27 Sedlak J., Lindsay R.H. Estimation of total protein bound and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal. Biochem. (1968) 25 192–195.
- 28 Wong W.S., Rahwan R.G., Stephens R.L. Jr Examination of the potential antiulcer activity of the calcium antagonist propyl-methylenedioxyindene. III. Lack of effect on cysteamine-induced duodenal ulcers in rats. Pharmacology (1990) 41 215–223.
- 29 Pascaud X.B., Chovet M., Soulard P., Chevalier E., Roze C., Junien J.L. Effects of a new sigma ligand, JO 1784, on cysteamine ulcers and duodenal alkaline secretion in rats. Gastroenterology (1993) 104 427–434.
- 30 Tariq M., Elfaki I., Khan H.A., Arshaduddin M., Sobki S., Al Moutaery M. Bromophenacyl bromide, a phospholipase A2 inhibitor attenuates chemically induced gastroduodenal ulcers in rats. World J. Gastroenterol. (2006) 13 5798–5804.
- 31 Tariq M., Moutaery M.A., Elfaki I., Arshaduddin M., Khan H.A. Protective effects of nedocromil sodium and sodium cromoglycate on gastroduodenal ulcers: a comparative study in rats. Inflammopharmacol (2006) 14 163–169.
- 32 Nishida A., Takinami Y., Yuki H. et al. YMO22 {(R)-1-(2,3-dihydro-1-(2-methyl-phenacyl)-2-oxo-5-phenyl-1H-14-benzodiazepin-3-yl)-3-(3-methylphenyl)-urea}, a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric duodenal lesions in rats. J. Pharmacol. Exp. Ther. (1994) 270 1256–1261.
- 33 Pendley C.E., Fitzpatrick L.R., Capolino A.J. et al. RP 73870, a gastrin/cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat. J. Pharmacol. Exp. Ther. (1995) 273 1015–1022.
- 34 Tariq M., Parmar N.S., Aqeel A.M. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats. J. Pharmacol. Exp. Ther. (1987) 241 602–607.
- 35 Hung C.R. Low susceptibility of stress ulcer in diabetic rats: role of cholinergic gastric motility. Clin. J. Physiol. (1998) 41 151–159.
- 36 Yamamoto S., Kaneko H., Konagawa T. et al. Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori positive peptic ulcer patients. Helicobacter. (2001) 6 136–145.
- 37 Robert A., Nezamis J.E., Lancaster C., Hanchar A.J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology (1979) 77 433–443.
- 38 Ota S., Hiraishi H., Terano A. et al. The effect of cimetidine on adaptive cytoprotection by mild irritant dose of HCl in the rat gastric mucosa. Jpn. J. Pharmacol. (1991) 57 63–69.
- 39 Liss R.H., Letourneau R.J., Schepis J.P. Evaluation of cytoprotection against ethanol-induced injury in gastric mucosa pretreated with misoprostol, cimetidine, or placebo. Dig. Dis. Sci. (1986) 31 108S–114S.
- 40 Robert A., Lancaster C., Davis J.P., Field S.O., Nezamis J.E. Distinction between antiulcer effect and cytoprotection. Scand. J. Gastroenterol. Suppl. (1984) 101 69–73.
- 41 Takeda F., Kitagawa H., Kohei H. Gastric cytoprotection by pirenzepine in rats: evaluating method for cytoprotective activity by antisecretory agents. Jpn. J. Pharmacol. (1985) 38 337–346.
- 42 Kusterer K., Rohr G., Herrmann W. et al. The role of gastric and duodenal pH in the cysteamine-induced duodenal ulcer in the rat. Acta Physiol. Hung. (1989) 73 247–250.
- 43 Gallagher G., Brown A., Szabo S. Effect of dopamine-related drugs on duodenal ulcer induced by cysteamine or propionitrile: prevention and aggravation may not be mediated by gastrointestinal secretory changes in the rat. J. Pharmacol. Exp. Ther. (1987) 240 883–889.
- 44 Glavin G.B. Activity of selective dopamine DA1 and DA2 agonists and antagonists on experimental gastric lesions and gastric acid secretion. J. Pharmacol. Exp. Ther. (1989) 251 726–730.
- 45 Szabo S., Khomenko T., Gombos Z., Deng X.M., Jadus M.R., Yoshida M. Review article: transcription factors and growth factors in ulcer healing. Aliment. Pharmacol. Ther. (2000) 14 33–43.
- 46 Chen S.H., Pan S., Okita K., Takemoto T. Role of oxygen-derived free radicals in the mechanism of cysteamine-induced duodenal ulcer in rats. J. Formos. Med. Assoc. (1994) 93 11–14.
- 47 Koleckar V., Jun D., Opletal L., Jahodar L., Kuca K. Assay of radical scavenging activity of antidotes against chemical warfare agents by DPPH test using sequential injection technique. J. Appl. Biomed. (2007) 5 81–84.
- 48 Troskot B., Simicevic V.N., Dodig M., Rotkvic I., Ivankovic D., Duvnjak M. The protective effect of zinc sulphate pretreatment against duodenal ulcers in the rat. Biometals (1997) 10 325–329.
- 49 Velinov H., Mileva M., Nachev C. Influence of acute copper deficiency, cold-restraint stress and the H2 blocker ranitidine on the severity of acute gastric mucosal lesions and lipid peroxidation in rats. Methods Find. Exp. Clin. Pharmacol. (2001) 23 401–407.
- 50 Wang X. Aspirin-like drugs cause gastrointestinal injuries by metallic cation chelation. Med. Hypoth. (1998) 50 227–238.
- 51 Bell A.E., Sellers L.A., Allen A. et al. Properties of gastric and duodenal mucus: effects of proteolysis, disulfide reduction, bile, acid, ethanol and hypertonicity on mucus gel structure. Gastroenterology (1985) 88 269–280.
- 52 Slomiany B.L., Piasek A., Sarosiek J. et al. The role of surface and intracellular mucus in gastric mucosal protection against hydrogen ion. Compositional differences. Scand. J. Gastroenterol. (1985) 20 1191–1196.
- 53 Allen A., Sellers L.A., Bennett M.K. The gastric mucosal epithelial barrier: role of mucus and fibrin. Scand. J. Gastroenterol. (1987) 20 1191–1196.
- 54 Wallace J.L., Whittle B.J.R. Role of mucus in the repair of gastric epithelial damage in the rat. Gastroenterology (1986) 91 603–611.
- 55 Guardia T., Guzman J.A., Pestchanker M.J. et al. Mucus synthesis and sulfhydryl groups in cytoprotection mediated by dehydroleucodine, a sequiterpene lactone. J. Natl. Prod. (1994) 57 507–509.
- 56 Salim A.S. Sulfhydryl-containing agents: a new approach to the problem of refractory peptic ulceration. Pharmacology (1992) 45 301–306.
- 57 Tariq M., Khan H.A., Elfaki I. et al. Gastric antisecretory and antiulcer effects of simvastatin in rats. J. Gastroenterol. Hepatol. (2006) 22 2316–2323.
- 58 Takeuchi K., Ueshima K., Hironaka Y., Fujioka Y., Matsumoto J., Okabe S. Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats. Relation to gastric hypermotility. Digestion (1991) 49 175–184.
- 59 Bhattacharjee M., Bhattacharjee S., Gupta A., Banerjee R.K. Critical role of an endogenous gastric peroxidase in controlling oxidative damage in H. pylori-mediated and nonmediated gastric ulcer. Free Radic. Biol. Med. (2002) 32 731–743.
- 60 Al Moutairy A.R., Tariq M. Effect of vitamin E and selenium on hypothermic restraint stress and chemically-induced ulcers. Dig. Dis. Sci. (1996) 41 1165–1171.
- 61 Tariq M. Gastric anti-ulcer and cytoprotective effect of vitamin E in rats. Res. Commun. Chem. Pathol. Pharmacol. (1988) 60 87–96.
- 62 Yokota T., Ohami H., Ohishi H., Hattori T., Watanabe K. Repression of acute gastric mucosal lesions by antioxidant-containing fraction from fermented products of okara (bean-curd residue). J. Nutr. Sci. Vitamino. (1996) 42 167–172.
- 63 Hiraishi H., Terano A., Ota S. et al. Protection of cultured rat gastric cells against oxidant induced damage by exogenous glutathione. Gastroenterology (1994) 106 1199–1207.
- 64 Sener-Muratoglu G., Paskaloglu K., Arbak S., Hurdag C., Ayanoglu-Dulger G. Protective effect of famotidine, omeprazole, and melatonin against acetylsalicyclic acid induced gastric damage in rats. Dig. Dis. Sci. (2001) 46 318–330.
- 65 Hernandez-Munoz R., Montiel Ruiz C., Vazquez-Martinez O. Gastric mucosal cell proliferation in ethanol-induced chronic mucosal injury is related to oxidative stress and lipid peroxidation in rats. Lab. Invest. (2000) 80 1161–1169.